Federica Elia
Catania, 95123, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Long-Term Survival with Daratumumab, Lenalidomide and Dexamethasone in Transplant-Ineligible Newly Diagnosed Multiple Myeloma Patients-A Survey from Two Italian Centers.
Journal: Diseases (Basel, Switzerland)
Published: December 17, 2025
Correction to: Continous or fixed carfilzomib, lenalidomide and dexamethasone (KRD) for relapsed-refractory multiple myeloma: long-term follow-up from a multicenter, retrospective real-life survey from European myeloma network (EMN) Italy : Correction to: annals of hematology.
Journal: Annals of hematology
Published: November 12, 2025
IgG-k/IgG-λ Para-Osseous Plasmacytoma Relapsed as Soft-Tissue Plasmacytoma with IgA-k Immunophenotype: A Case Report and Review of the Literature on Related Biochemical Aspects.
Journal: Hematology reports
Published: March 16, 2024
Multiple Myeloma in 2023 Ways: From Trials to Real Life.
Journal: Current oncology (Toronto, Ont.)
Published: September 30, 2023
Lenalidomide plus Dexamethasone Combination as First-Line Oral Therapy of Multiple Myeloma Patients: A Unicentric Real-Life Study.
Journal: Cancers
Published: June 05, 2023
Multicentric Castleman Disease and Concurrent Hematological Disorders: The Occurrence of Plasmacytoma and the Hypotheses Arising from Literature Review.
Journal: Acta haematologica
Published: December 09, 2022
Poly (ADP-ribose) polymerase-1 (PARP-1) -410C/T polymorphism in Sicilian patients with Parkinson's disease.
Journal: Journal of the neurological sciences
Published: November 30, 2015
Showing 1-8 of 8
Last Updated: 09/26/2026